AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Our data on the regulation of pro- and anti-apoptotic molecules, together with the activation of ERK and Akt pathways, suggest that CML exosomes trigger an anti-apoptotic phenotype in the producer cells.